Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Sara De Carolis; Sara Tabacco

doi:10.1016/j.ajog.2017.08.113

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Sara De Carolis, Sara Tabacco

Risultato della ricerca: Contributo in rivista › Articolo in rivista

2 Citazioni (Scopus)

Abstract

We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

Lingua originale	English
pagine (da-a)	711-712
Numero di pagine	2
Rivista	American Journal of Obstetrics and Gynecology
Volume	217
DOI	https://doi.org/10.1016/j.ajog.2017.08.113
Stato di pubblicazione	Pubblicato - 2017

Keywords

Antibodies, Antiphospholipid
Antiphospholipid Syndrome
Female
Humans
Hydroxychloroquine
Obstetrics and Gynecology
Pregnancy

Accesso al documento

10.1016/j.ajog.2017.08.113

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{5c9ed1777a644718836ab396aeb1eafd,

title = "Hydroxychloroquine as additional treatment in pregnant patients with refractory APS",

abstract = "We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.",

keywords = "Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Female, Humans, Hydroxychloroquine, Obstetrics and Gynecology, Pregnancy, Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Female, Humans, Hydroxychloroquine, Obstetrics and Gynecology, Pregnancy",

author = "{De Carolis}, Sara and Sara Tabacco",

year = "2017",

doi = "10.1016/j.ajog.2017.08.113",

language = "English",

volume = "217",

pages = "711--712",

journal = "American Journal of Obstetrics and Gynecology",

issn = "0002-9378",

publisher = "Mosby Year Book Incorporated:6277 Sea Harbor Drive:Orlando, FL 32887:(800)654-2452, (407)345-4000, EMAIL: hhspcs@harcourt.com, INTERNET: http://www.mosby.com, Fax: (407)363-9661, (314)432-1380",

}

TY - JOUR

T1 - Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

AU - De Carolis, Sara

AU - Tabacco, Sara

PY - 2017

Y1 - 2017

N2 - We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

AB - We greatly appreciated the results of the PREGNancy in women with ANTiphospholipid Syndrome study by Saccone et al1 assessing the risk of obstetric complications in women with primary antiphospholipid syndrome (APS) that is associated with a specific antibody profile.

KW - Antibodies, Antiphospholipid

KW - Antiphospholipid Syndrome

KW - Female

KW - Humans

KW - Hydroxychloroquine

KW - Obstetrics and Gynecology

KW - Pregnancy

KW - Antibodies, Antiphospholipid

KW - Antiphospholipid Syndrome

KW - Female

KW - Humans

KW - Hydroxychloroquine

KW - Obstetrics and Gynecology

KW - Pregnancy

UR - http://hdl.handle.net/10807/112090

U2 - 10.1016/j.ajog.2017.08.113

DO - 10.1016/j.ajog.2017.08.113

M3 - Article

VL - 217

SP - 711

EP - 712

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

ER -

Hydroxychloroquine as additional treatment in pregnant patients with refractory APS

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo